BR0113140A - Antagonistas de receptor de ccr1 não peptìdico em combinação com ciclosporina a para o tratamento da rejeição de transplante de coração - Google Patents

Antagonistas de receptor de ccr1 não peptìdico em combinação com ciclosporina a para o tratamento da rejeição de transplante de coração

Info

Publication number
BR0113140A
BR0113140A BR0113140-0A BR0113140A BR0113140A BR 0113140 A BR0113140 A BR 0113140A BR 0113140 A BR0113140 A BR 0113140A BR 0113140 A BR0113140 A BR 0113140A
Authority
BR
Brazil
Prior art keywords
treatment
transplant rejection
heart transplant
combination
ccr1 receptor
Prior art date
Application number
BR0113140-0A
Other languages
English (en)
Inventor
Richard Horuk
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of BR0113140A publication Critical patent/BR0113140A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"ANTAGONISTAS DE RECEPTOR DE CCR1 NãO PEPTìDICO EM COMBINAçãO COM CICLOSPORINA A PARA O TRATAMENTO DA REJEIçãO DE TRANSPLANTE DE CORAçãO". A presente invenção se refere a composições farmacêuticas úteis no tratamento da rejeição de transplante de coração em mamíferos, e método de administração de composição farmacêutica útil no tratamento da rejeição ao transplante de coração em mamíferos as quais compreendem um excipiente farmaceuticamente aceitável, uma quantidade terapeuticamente eficaz de um antagonista de receptor de CCR1 não peptídico e uma quantidade subnefrotóxica de ciclosporina A.
BR0113140-0A 2000-07-31 2001-07-31 Antagonistas de receptor de ccr1 não peptìdico em combinação com ciclosporina a para o tratamento da rejeição de transplante de coração BR0113140A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22205300P 2000-07-31 2000-07-31
US23128200P 2000-09-08 2000-09-08
US09/915,411 US6740636B2 (en) 2000-07-31 2001-07-25 Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
PCT/US2001/023862 WO2002009762A2 (en) 2000-07-31 2001-07-31 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection

Publications (1)

Publication Number Publication Date
BR0113140A true BR0113140A (pt) 2003-06-24

Family

ID=27397025

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0113140-0A BR0113140A (pt) 2000-07-31 2001-07-31 Antagonistas de receptor de ccr1 não peptìdico em combinação com ciclosporina a para o tratamento da rejeição de transplante de coração

Country Status (28)

Country Link
US (1) US6740636B2 (pt)
EP (1) EP1305047B1 (pt)
JP (1) JP2004530630A (pt)
KR (1) KR20030048000A (pt)
CN (1) CN1655818A (pt)
AT (1) ATE330634T1 (pt)
AU (2) AU2001278073B2 (pt)
BG (1) BG107502A (pt)
BR (1) BR0113140A (pt)
CA (1) CA2417636A1 (pt)
CY (1) CY1105321T1 (pt)
DE (1) DE60120986T2 (pt)
DK (1) DK1305047T3 (pt)
EE (1) EE200300047A (pt)
ES (1) ES2261447T3 (pt)
HR (1) HRP20030121A2 (pt)
HU (1) HUP0300686A3 (pt)
IL (1) IL153933A0 (pt)
LV (1) LV13033B (pt)
MX (1) MXPA03000836A (pt)
NO (1) NO20030475L (pt)
NZ (1) NZ523688A (pt)
PL (1) PL364521A1 (pt)
PT (1) PT1305047E (pt)
SI (1) SI21123A (pt)
SK (1) SK1222003A3 (pt)
WO (1) WO2002009762A2 (pt)
YU (1) YU6703A (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004266153A1 (en) * 2003-08-22 2005-03-03 Bayer Schering Pharma Aktiengesellschaft Chemokine inhibiting piperazine derivatives and their use to treat myocarditis
US7917195B2 (en) 2004-03-05 2011-03-29 Lifesciences Solutions LLC Systems, methods and computer program products for heart monitoring
US10499828B2 (en) * 2004-03-05 2019-12-10 Lifescience Solutions, Llc System and method for heart monitoring
US8103065B2 (en) * 2006-01-05 2012-01-24 Lifescience Solutions Llc Assessment of medical conditions
US20110009758A1 (en) * 2009-07-10 2011-01-13 Lifescience Solutions Llc System and method for heart monitoring

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323206B1 (en) 1996-07-12 2001-11-27 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6403587B1 (en) 1997-02-26 2002-06-11 Pfizer Inc. Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-α binding to its CCR 1 receptor
US6207665B1 (en) * 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
EP1047675A1 (en) 1998-01-21 2000-11-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
DE69928226T8 (de) 1998-01-21 2006-10-19 Millennium Pharmaceuticals, Inc., Cambridge Chemokin rezeptor antagonisten und verwendung
UA57824C2 (uk) 1998-02-05 2003-07-15 Пфайзер Продактс Інк. Похідні дигідроксигексанової кислоти, фармацевтична композиція, що їх містить (варіанти), та спосіб лікування (варіанти)
EP1000626A1 (en) 1998-09-18 2000-05-17 Applied Research Systems ARS Holding N.V. Chemokine receptor antagonist and cyclosporin in combined therapy
JP2002535358A (ja) 1999-01-29 2002-10-22 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 移植片拒絶反応及び虚血−再灌流障害の予防方法

Also Published As

Publication number Publication date
JP2004530630A (ja) 2004-10-07
EP1305047A2 (en) 2003-05-02
CN1655818A (zh) 2005-08-17
NZ523688A (en) 2005-04-29
DK1305047T3 (da) 2006-10-23
LV13033B (en) 2004-02-20
CA2417636A1 (en) 2002-02-07
US6740636B2 (en) 2004-05-25
WO2002009762A3 (en) 2003-01-09
EP1305047B1 (en) 2006-06-21
CY1105321T1 (el) 2010-03-03
NO20030475L (no) 2003-03-28
BG107502A (en) 2003-07-31
AU2001278073B2 (en) 2005-06-30
AU7807301A (en) 2002-02-13
ATE330634T1 (de) 2006-07-15
WO2002009762A2 (en) 2002-02-07
PL364521A1 (en) 2004-12-13
HUP0300686A2 (hu) 2003-08-28
PT1305047E (pt) 2006-11-30
SK1222003A3 (en) 2003-09-11
KR20030048000A (ko) 2003-06-18
DE60120986T2 (de) 2006-11-23
HRP20030121A2 (en) 2005-02-28
NO20030475D0 (no) 2003-01-30
DE60120986D1 (de) 2006-08-03
IL153933A0 (en) 2003-07-31
MXPA03000836A (es) 2003-06-06
US20020039997A1 (en) 2002-04-04
HUP0300686A3 (en) 2005-03-29
SI21123A (sl) 2003-08-31
EE200300047A (et) 2004-10-15
ES2261447T3 (es) 2006-11-16
YU6703A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
CO5251419A1 (es) Composiciones nanoparticuladas de eplerenona
CA2427227A1 (en) Lactam compound
BR0008059A (pt) Composições de valdecoxib
EA200900264A1 (ru) Композиции флибансерина и способ их приготовления
IL151503A0 (en) Therapeutic combinations of antihypertensive and antiagiogenic agents
NO20052739L (no) CCR5-antagonister som medikamenter
NZ535616A (en) Indolymaleimide derivatives as protein kinase c inhibitors
BR0115965A (pt) Composições farmacêuticas para a liberação oral de agentes farmacologicamente ativos
MY144897A (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
IL150895A0 (en) Oral, nasal and pulmonary formulations of copolymer-1
ECSP066878A (es) [hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa
MA30466B1 (fr) Nouvelle forme d'administration du racecadotril
WO2006115770A3 (en) Orally disintegrating pharmaceutical tablet formulations of olanzapine
HUP0400553A2 (hu) Gyógyászati készítmények
HUP0400115A2 (hu) Gyógyászati készítmény fulvesztrant intramuszkuláris beadására
BR0113140A (pt) Antagonistas de receptor de ccr1 não peptìdico em combinação com ciclosporina a para o tratamento da rejeição de transplante de coração
SE9902935D0 (sv) Pharmaceutical compositions
MY143571A (en) Eplerenone crystalline form
ATE277639T1 (de) Zusammensetzungen von adenosin a1 agonisten und 5ht3 agonisten
WO2002053099A3 (en) Methods and compositions for treating periodontal disease
ATE323532T1 (de) Nicht-peptidische ccr1-rezeptor-antagonisten zur behandlung der progressiven nierenfibrose
DE602006016168D1 (de) 1,3,5-triazepin-dionen zur Behandlung von Malaria
LT2003015A (en) Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection
WO2009095395A3 (en) Pharmaceutical compositions
KR20240008903A (ko) 향정신성 작용제 및 그의 용도

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6AE7A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.